Powered by Truveo

Video

Search for video:
More Search Options
QualityStocks Daily Video 02/13/2007
Duration: 4:17Source: YouTube
Welcome to The Daily Stock Report...brought to you by QualityStocks.Net, performance tracked daily. I'm Cathy Rankin and for Monday February 13th.... we're bringing you the latest news from around the markets as well as the top movers to look out for today... In Headline News Today... The selling continued Monday as investors weighed ongoing uncertainty about Fed policy and the collapse of some noteworthy M&A deals against a sell-off in oil. However, reports that Sanofi-Aventis called off merger talks with Bristol-Myers and Nasdaq failed again to get shareholder approval for its hostile takeover of the London Stock Exchange merely left investors questioning valuations and the market's weakening fundamentals. Stocks running virtually unabated since July of last year, without any real setback, has raised concerns that a correction is coming; worries that we believe will make it difficult for any sustained move to the upside in the near-term. Market participants also erred on the side of caution as they awaited clues about the interest rate outlook. All eyes this week will be on Fed Chairman Bernanke as he goes before the Senate and House Committees Wednesday and Thursday, respectively, to provide his semi-annual testimony on the economy and monetary policy. In Our Small Cap News today... Onyx Pharmaceuticals Inc. shares doubled as news released on Sunday that an independent monitoring committee found a Phase 3 trial of Nexavar had met its endpoint. Further analysis of safety and efficacy data found the drug, which is being developed by Onyx and Bayer, offered better overall survival in primary liver cancer patients, and did not result in higher adverse event rates compared with the placebo. Both companies are still in talks with health authorities worldwide to determine the next steps in approval the drug in treating primary liver cancer. Onyx Pharmaceuticals (ONXX) previously at $12.26 a share opens up 97% at $24.19 a share with over 54 Million shares traded by Mondays close. Brush Engineered Materials shares soared after the provider of alloy and electronic products posted better-than-expected fourth-quarter results and issued a strong guidance on Monday. Brush issued an outlook for full-year 2007 profit above Wall Street's expectations. The company said that the growth was driven by continued strength from telecommunications infrastructure product applications and an increased demand from consumer electronics customers, along with the oil and gas and heavy equipment markets. Previously at $31.36 a share Brush opens today up 33% at $41.81 a share with over 2 Million shares traded. Magellan Energy Ltd. announced last Tuesday the companies corporate update for quarter 1 2007 Magellan Energy Ltd. currently has an option to acquire up to 200 low producing oil wells located in the domestic United States. The Company will be deciding which of the options its wishes to trigger and will be looking for the wells that will offer the most cost effective and profitable returns. Magellan is a growing and experienced energy company focused on acquiring and partnering with existing producing junior properties in North America. Previously at $2.15 a share Magellan opens today up 30% or $2.80 a share. And that's it for the news makers... Be sure to join us every market day for the latest commentary... on small cap to large cap and everything in between brought to you by Quality Stocks. Net. Also be sure to watch for "The QualityStocks Daily Newsletter" available each trading day through QualityStocks.Net Thank you for tuning in, I'm Cathy Rankin. Have a great day and we'll see you tomorrow, right here on the daily report.
Rating: (0 ratings) Views: 43 Added: Sep 25, 2007
Category: Author: QualityStocks
Email This

About  Advertise  Contact  Privacy Policy  Terms
© 2008 Find Internet TV. All rights reserved.
All brand, company, and product names are trademarks or registered trademarks of their respective owners.